Search

everythinglearnresearchcommunity

for

Search:↓

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Alopecia areata greatly affects quality of life, needing psychological support.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

Alopecia areata greatly affects the quality of life for children and their families.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Certain hair and scalp features can predict the severity of alopecia areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

More lesions mean more severe alopecia areata.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

CAR is a useful marker for assessing alopecia areata severity.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Patients with alopecia areata in the UK face barriers to care, needing better-defined pathways and more education for general practitioners.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.